In this week's Lunch and Learn with Dr. Berry podcast, we talk about COVID-19 and, more especially, an updated COVID-19 vaccine for kids. After several delays, extremely young children such as newborns, toddlers, and preschoolers are now eligible to receive the COVID-19 vaccine. More specifically, the FDA has approved the Moderna and Pfizer vaccines for children between the ages of 6 months and 5 years. Parents all throughout the nation have been awaiting this decision because this is the last age group that has been left unprotected when the pandemic first began.
With over 5.7 million of the 13+ million reported instances of COVID-19 occurring this year alone, parents, caregivers, and medical professionals have been crying out for assistance, and it has now been granted.
Today, I'll cover a wide range of topics that will inform us. Here is a list of the main topics that will be discussed;
- FDA approval of Covid-19 vaccine for Kids
- COVID-19 update
- COVID-19 stats for kids
- Waiting on CDC approval
- Differences between Moderna & Pfizer COVID-19 vaccines
Links/Resources:
- Dr. Berry's Website
- DrBerryPierreTV
- Dr. Pierre's Healthchecks
- Dr. Berry's Twitter
- Dr. Berry's Instagram
- Dr. Berry's Clubhouse
- Dr. Berry's TikTok page
- FDA Authorizes Moderna and Pfizer-BioNTech COVID-19 Vaccines for Children Down to 6 Months of Age
Prior Episodes
- Should I wait to get the COVID-19 Vaccine?
- My Covid Vaccine Experience
- My Final Covid-19 Vaccine Experience
- New Covid-19 Vaccine On The Block
- Why did the FDA pause the Johnson and Johnson Vaccine?
- How did we get a covid-19 vaccine back so fast?
Sponsors:
- Lunch and Learn Community Online Store (code Empower10)
- Pierre Medical Consulting (If you are looking to expand your social reach and make your process automated then Pierre Medical Consulting is for you)
- Dr. Pierre's Resources – These are some of the tools I use to become successful using social media
- My Amazon Store – Check out all of the book recommendations you heard in the episode
- Autism in Black Conference